Source author record

Michael Inouye

Michael Inouye appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Applications Emerging Technologies Genomics Hardware Architecture Molecular Networks

Catalog footprint

What is connected

3works

5topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2021arXiv

Known allosteric proteins have central roles in genetic disease

Allostery is a form of protein regulation, where ligands that bind sites located apart from the active site can modify the activity of the protein. The molecular mechanisms of allostery have been extensively studied, because allosteric sites are less conserved than active sites, and drugs targeting them are more specific than drugs binding the active sites. Here we quantify the importance of allostery in genetic disease. We show that 1) known allosteric proteins are central in disease networks, and contribute to genetic disease and comorbidities much more than non-allosteric proteins, in many major disease types like hematopoietic diseases, cardiovascular diseases, cancers, diabetes, or diseases of the central nervous system. 2) variants from cancer genome-wide association studies are enriched near allosteric proteins, indicating their importance to polygenic traits; and 3) the importance of allosteric proteins in disease is due, at least partly, to their central positions in protein-protein interaction networks, and probably not due to their dynamical properties.

preprint2020arXiv

FPGA Based Emulation Environment for Neuromorphic Architectures

Neuromorphic architectures such as IBM's TrueNorth and Intel's Loihi have been introduced as platforms for energy efficient spiking neural network execution. However, there is no framework that allows for rapidly experimenting with neuromorphic architectures and studying the trade space on hardware performance and network accuracy. Fundamentally, this creates a barrier to entry for hardware designers looking to explore neuromorphic architectures. In this paper we present an open-source FPGA based emulation environment for neuromorphic computing research. We prototype IBM's TrueNorth architecture as a reference design and discuss FPGA specific design decisions made when implementing and integrating it's core components. We conduct resource utilization analysis and realize a streaming-enabled TrueNorth architecture on the Zynq UltraScale+ MPSoC. We then perform functional verification by implementing networks for MNIST dataset and vector matrix multiplication (VMM) in our emulation environment and present an accuracy-based comparison based on the same networks generated using IBM's Compass simulation environment. We demonstrate the utility of our emulation environment for hardware designers and application engineers by altering the neuron behavior for VMM mapping, which is, to the best of our knowledge, not feasible with any other tool including IBM's Compass environment. The proposed parameterized and configurable emulation platform serves as a basis for expanding its features to support emerging architectures, studying hypothetical neuromorphic architectures, or rapidly converging to hardware configuration through incremental changes based on bottlenecks as they become apparent during application mapping process.

preprint2013arXiv

Accurate and robust genomic prediction of celiac disease using statistical learning

Practical application of genomic-based risk stratification to clinical diagnosis is appealing yet performance varies widely depending on the disease and genomic risk score (GRS) method. Celiac disease (CD), a common immune-mediated illness, is strongly genetically determined and requires specific HLA haplotypes. HLA testing can exclude diagnosis but has low specificity, providing little information suitable for clinical risk stratification. Using six European CD cohorts, we provide a proof-of-concept that statistical learning approaches which simultaneously model all SNPs can generate robust and highly accurate predictive models based on genome-wide SNP profiles. The high predictive capacity replicated both in cross-validation within each cohort (AUC of 0.87-0.89) and in independent replication across cohorts (AUC of 0.86-0.9), despite differences in ethnicity. The models explained 30-35% of disease variance and up to $\sim43\%$ of heritability. The GRS's utility was assessed in different clinically relevant settings. Comparable to HLA typing, the GRS can be used to identify individuals without CD with $\geq99.6\%$ negative predictive value however, unlike HLA typing, patients can also be stratified into categories of higher-risk for CD who would benefit from more invasive and costly definitive testing. The GRS is flexible and its performance can be adapted to the clinical situation by adjusting the threshold cut-off. Despite explaining a minority of disease heritability, our findings indicate a predictive GRS provides clinically relevant information to improve upon current diagnostic pathways for CD, and support further studies evaluating the clinical utility of this approach in CD and other complex diseases.